Maria Prat

Prof. Dr. Maria Prat

Department of Health Sciences, School of Medicine, Università del Piemonte Orientale “A. Avogadro”, Novara, Italy
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2013 in Langmuir
Verified
Journal Article
Closed access
IRIsaac Rodríguez-Ruiz
Isaac Rodríguez-Ruiz
JDJosé Manuel Delgado-López
José Manuel Delgado-López
MDMiguel A. Durán-Olivencia
Miguel A. Durán-Olivencia
Michele IafiscoMichele Iafisco
Michele Iafisco
ATAnna Tampieri
Anna Tampieri
Jaime Gómez MoralesJaime Gómez Morales
Jaime Gómez Morales

18 April 2013 in Small
Verified
Journal Article
Closed access
PDF file
Michele IafiscoMichele Iafisco
Michele Iafisco
JDJosé Manuel Delgado-López
José Manuel Delgado-López
Elena Maria VaroniElena Maria Varoni
Elena Maria Varoni
ATAnna Tampieri
Anna Tampieri
Lia RimondiniLia Rimondini
Lia Rimondini
MPMaria Prat
Maria Prat

11 December 2013 in Stem Cells and Development
Verified
Journal Article
Closed access
SPStefano Pietronave
Stefano Pietronave
AZAndrea Zamperone
Andrea Zamperone
FOFrancesca Oltolina
Francesca Oltolina
Donato ColangeloDonato Colangelo
Donato Colangelo
Antonia FollenziAntonia Follenzi
Antonia Follenzi
MPMaria Prat
Maria Prat
Electrical stimulation (ES) of cells has been shown to induce a variety of responses, such as cytoskeleton rearrangements, migration, proliferation, and differentiation. In this study, we have investigated whether monophasic and biphasic pulsed ES could exert any effect on the proliferation and differentiation of human cardiac progenitor cells (hCPCs) isolated from human heart fragments. Cells were cultured under continuous exposure to monophasic or biphasic ES with fixed cycles for 1 or 3 days. Results indicate that neither stimulation protocol affected cell viability, while the cell shape became more elongated and reoriented more perpendicular to the electric field direction. Moreover, the biphasic ES clearly induced the upregulation of early cardiac transcription factors, MEF2D, GATA-4, and Nkx2.5, as well as the de novo expression of the late cardiac sarcomeric proteins, troponin T, cardiac alpha actinin, and SERCA 2a. Both treatments increased the expression of connexin 43 and its relocation to the cell membrane, but biphasic ES was faster and more effective. Finally, when hCPCs were exposed to both monophasic and biphasic ES, they expressed de novo the mRNA of the voltage-dependent calcium channel Cav 3.1(α 1G ) subunit, which is peculiar of the developing heart. Taken together, these results show that ES alone is able to set the conditions for early differentiation of adult hCPCs toward a cardiac phenotype.

9 September 2020 in Cancers
Verified
Journal Article
Open access
PDF file
FOFrancesca Oltolina
Francesca Oltolina
APAna Peigneux
Ana Peigneux
Donato ColangeloDonato Colangelo
Donato Colangelo
NCNausicaa Clemente
Nausicaa Clemente
ADANNARITA D'URSO
ANNARITA D'URSO
MPMaria Prat
Maria Prat
Biomimetic magnetic nanoparticles mediated by magnetosome proteins (BMNPs) are potential innovative tools for cancer therapy since, besides being multifunctional platforms, they can be manipulated by an external gradient magnetic field (GMF) and/or an alternating magnetic field (AMF), mediating targeting and hyperthermia, respectively. We evaluated the cytocompatibility/cytotoxicity of BMNPs and Doxorubicin (DOXO)-BMNPs in the presence/absence of GMF in 4T1 and MCF-7 cells as well as their cellular uptake. We analyzed the biocompatibility and in vivo distribution of BMNPs as well as the effect of DOXO-BMNPs in BALB/c mice bearing 4T1 induced mammary carcinomas after applying GMF and AMF. Results: GMF enhanced the cell uptake of both BMNPs and DOXO-BMNPs and the cytotoxicity of DOXO-BMNPs. BMNPs were biocompatible when injected intravenously in BALB/c mice. The application of GMF on 4T1 tumors after each of the repeated (6×) iv administrations of DOXO-BMNPs enhanced tumor growth inhibition when compared to any other treatment, including that with soluble DOXO. Moreover, injection of DOXO-BMNPs in the tumor combined with application of an AMF resulted in a significant tumor weight reduction. These promising results show the suitability of BMNPs as magnetic nanocarriers for local targeted chemotherapy and as local agents for hyperthermia.
1

10 January 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
Jaime Gómez MoralesJaime Gómez Morales
Jaime Gómez Morales
Cristobal Verdugo-EscamillaCristobal Verdugo-Escamilla
Cristobal Verdugo-Escamilla
RFRaquel Fernández-Penas
Raquel Fernández-Penas
CPCarmen María Parra-Milla
Carmen María Parra-Milla
Christophe DrouetChristophe Drouet
Christophe Drouet
JFJorge Fernandez-Sanchez
Jorge Fernandez-Sanchez
Nanomedicine covers the application of nanotechnologies in medicine. Of particular interest is the setup of highly-cytocompatible nanoparticles for use as drug carriers and/or for medical imaging. In this context, luminescent nanoparticles are appealing nanodevices with great potential for imaging of tumor or other targetable cells, and several strategies are under investigation. Biomimetic apatite nanoparticles represent candidates of choice in nanomedicine due to their high intrinsic biocompatibility and to the highly accommodative properties of the apatite structure, allowing many ionic substitutions. In this work, the preparation of biomimetic (bone-like) citrate-coated carbonated apatite nanoparticles doped with europium ions is explored using the citrate-based thermal decomplexing approach. The technique allows the preparation of the single apatitic phase with nanosized dimensions only at Eu3+ doping concentrations ≤0.01 M at some timepoints. The presence of the citrate coating on the particle surface (as found in bone nanoapatites) and Eu3+ substituting Ca2+ is beneficial for the preparation of stable suspensions at physiological pH, as witnessed by the ζ-potential versus pH characterizations. The sensitized luminescence features of the solid particles, as a function of the Eu3+ doping concentrations and the maturation times, have been thoroughly investigated, while those of particles in suspensions have been investigated at different pHs, ionic strengths and temperatures. Their cytocompatibility is illustrated in vitro on two selected cell types, the GTL-16 human carcinoma cells and the m17.ASC murine mesenchymal stem cells. This contribution shows the potentiality of the thermal decomplexing method for the setup of luminescent biomimetic apatite nanoprobes with controlled features for use in bioimaging.

6 November 2019 in Nanomaterials
Verified
Journal Article
Open access
PDF file
FOFrancesca Oltolina
Francesca Oltolina
Donato ColangeloDonato Colangelo
Donato Colangelo
Ivana MilettoIvana Miletto
Ivana Miletto
NCNausicaa Clemente
Nausicaa Clemente
Marta MiolaMarta Miola
Marta Miola
Antonia FollenziAntonia Follenzi
Antonia Follenzi
Tumor-targeted drug-loaded nanocarriers represent innovative and attractive tools for cancer therapy. Several magnetic nanoparticles (MNPs) were analyzed as potential tumor-targeted drug-loaded nanocarriers after functionalization with anti-Met oncogene (anti-Met/HGFR) monoclonal antibody (mAb) and doxorubicin (DOXO). Their cytocompatibility, stability, immunocompetence (immunoprecipitation), and their interactions with cancer cells in vitro (Perl’s staining, confocal microscopy, cytotoxic assays: MTT, real time toxicity) and with tumors in vivo (Perl’s staining) were evaluated. The simplest silica- and calcium-free mAb-loaded MNPs were the most cytocompatible, the most stable, and showed the best immunocompetence and specificity. These mAb-functionalized MNPs specifically interacted with the surface of Met/HGFR-positive cells, and not with Met/HGFR-negative cells; they were not internalized, but they discharged in the targeted cells DOXO, which reached the nucleus, exerting cytotoxicity. The presence of mAbs on DOXO-MNPs significantly increased their cytotoxicity on Met/HGFR-positive cells, while no such effect was detectable on Met/HGFR-negative cells. Bare MNPs were biocompatible in vivo; mAb presence on MNPs induced a better dispersion within the tumor mass when injected in situ in Met/HGFR-positive xenotumors in NOD/SCID-γnull mice. These MNPs may represent a new and promising carrier for in vivo targeted drug delivery, in which applied gradient and alternating magnetic fields can enhance targeting and induce hyperthermia respectively.
1